tert-Butyl 4-oxopentanoate

Catalog No.: 
ACSQJX601
CAS No.: 
2854-10-6
Molecular Formula: 
C9H16O3
Molecular Weight: 
172.22
tert-Butyl 4-oxopentanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$71.00In stockIn stock
250mg97%$118.00In stockIn stock
1g97%$322.00In stockIn stock
5g97%$1268.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-oxopentanoate
IUPAC Nametert-butyl 4-oxopentanoate
MDL No.MFCD24688249
Molecular FormulaC9H16O3
Molecular Weight172.22
SMILESCC(CCC(OC(C)(C)C)=O)=O
InChI KeyFVXIMLWFYMZNEU-UHFFFAOYSA-N
Synonymtert-butyl 4-oxopentanoate;levulinic acid t-butyl ester;Pentanoic acid, 4-oxo-, 1,1-dimethylethyl ester
CAS No.2854-10-6
PubChem CID15577827

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSQJX601 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3In Stock
  2. Plus
  3. ACGWST857 route compound structure diagram
    ACGWST857591-12-8In Stock
  4. Then
  5. ACSQJX601 route product structure diagram
    ACSQJX6012854-10-6In Stock
Inquiry

2. ACSQJX601 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSQJX601 route product structure diagram
    ACSQJX6012854-10-6In Stock
Inquiry

3. ACSQJX601 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSQJX601 route product structure diagram
    ACSQJX6012854-10-6In Stock
Inquiry

Comments (0)